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Thoracentesis with a chest tube insertion and drainage of large pleural effusion is widely performed in patients with 
malignant lung diseases. One potential problem with a conventional chest tube placement is occasional incomplete 
evacuation of effusion owing to inappropriate position of the tip where the drainage holes opened. We have 
developed a curved chest tube and evaluated the position of tip placement just after the placement and before 
removal on plain chest X-ray in 20 patients with massive pleural effusions due to lung cancer. In 15 of the 20 
patients, the tip of the tube was successfully positioned at the paravertebral gutter in posterobasal with higher 
drainage efficacy compared with other patients whose tube tips happened to be positioned at other sites. There were 
no significant complications. This study suggested that the curved chest tube would be safe and useful in completing 
drainage of pleural effusion. 
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Introduction 
Malignant pleural effusion is treated with chemical pleuro- 
desis and/or systemic chemotherapy (l-4). The key to 
successful chemical pleurodesis is complete evacuation 
of pleural effusion. Prompt and complete evacuation of 
effusion may relieve patients’ anxiety and discomfort and 
prevent complication (5). 
Chest tube placement is a commonly performed 
procedure; however, incomplete evacuation of effusion is 
occasionally noted owing to inappropriate positioning of 
the tube, since the procedure is often performed without 
fluoroscopic guidance at the bedside (6-8). Incomplete 
evacuation of the effusion requires repeated subse- 
quent thoracentesis and insertion of another catheter. It is 
therefore imperative that a simple, safe and more effec- 
tive device is developed. The currently used chest tube 
is a straight plastic tube with its own central metal trocar 
(9). 
We have developed a curved chest tube which consists 
of a curved plastic tube and its own straight central metal 
trocar. The efficacy of this unique device was tested in 
20 patients. There were no significant complications. 
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Materials and Methods 
PATIENTS 
Over a 2 year period, 20 patients with histologically or 
cytologically proven malignant pleural effusions were 
entered into this study. Criteria for inclusion were 
malignant pleural effusion without ultrasonograph or CT 
scan confirmation of fibrin septa and/or multiloculation, no 
previous chest tube drainage, an expected survival time of 
more than 3 months, no evidence of severe heart failure; no 
evidence of life-threatening metastatic disease of other sites 
and no evidence of allergy to lidocaine and a sclerosing 
agent, OK-432 (Chugai Pharmaceutical Co. Ltd, Tokyo, 
Japan) (10-12). 
DESCRIPTION OF THE CHEST TUBE 
The newly developed chest tube is 40 cm in length and 18 
French in size. It is made of clear plastic (Sumitomo 
Bakelite Co. Ltd, Tokyo, Japan). In order to place the tip of 
a tube that has drainage holes in an appropriate position 
in the pleural space, we have made the chest tube with 
smooth curved parts at 10 cm and 20 cm from the distal end 
(Plate 1). The tube is held straight with a central straight 
metal trocar; however, the tube becomes smoothly curved 
on removal of the metal trocar. Moreover, we made ten 
drainage holes at the distal part for effective drainage of 
pleural effusion. 
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TABLE 1. Patients’ characteristics 
Variable Categories No. of patients 
PLATE 1. The curved chest tube and the straight metal 
trocar. With the central straight metal trocar, the tube is 
held straight; however, the chest tube becomes curved 
smoothly on removal of the metal trocar. The trocar is 
held inside during penetration of the thoracic wall. The 
trocar is retracted after the penetration of the chest tube. 
TECHNIQUE OF CHEST TUBE PLACEMENT 
The technique of chest tube insertion is similar to conven- 
tional techniques (13,14). The chest tubes were inserted 
in the anterior axillary line and directed inferiorly and 
posteriorly. The procedures were done with neither fluoro- 
scopic nor CT guidance. 
CHEMICAL PLEURODESIS 
The chest tube was connected to underwater seal suction 
(10 cmH,O). After maximal evacuation of the pleural 
effusion, the chest tube was clamped and 10 ml of 1% 
lidocaine was instilled. Immediately thereafter, 10 Klinische 
Einheit units of OK-432 dissolved in 100 ml of 0.9% saline 
solution were injected into the chest tube. The tube 
remained clamped for 2 h, and the patient was repositioned 
every 30 min. The tube was then unclamped and placed 
again on suction. After 24 h, the drainage amount was 
assessed. If drainage was less than 50 ml per 8 h, the chest 
tube was removed. If the drainage amount was greater, a 
second dose was administered and then drainage was 
reassessed 24 h later. Treatment was considered unsuccess- 
ful if a large amount of fluid continued to drain. 
EVALUATION 
In order to evaluate the position of the tip of the chest 
tube, frontal and lateral chest X-rays (15) were taken after 
insertion and before removal of the tube. Evaluation of the 
position was defined based on the chest radiographs as (a) 
paravertebral gutter in posterobasal (13), (b) posterior and 
superior position of the pleural space (14) or (c) pleural 
space other than (a) or(b). We also assessed the evacuation 
efficacy of pleural effusion. The criterion was defined as (i) 
drainage efficacy more than 90%, (ii) drainage efficacy from 
75% to 90% or (iii) drainage efficacy less than 75%. 
Gender Male-female 14-6 
Age (years) Median 66 
Range 36-85 
Histology Adenocarcinoma 18 
Squamous cell carcinoma 2 
Stage IIIB 12 
IV 8 
TABLE 2. Evaluation of the position of the tip of a chest 
tube 
Position of distal 
end of catheter 
No. of 
patients (%) 
After insertion 
Paravertebral gutter in posterobasal 
Posterior and superior position 
Other position 
Before removal 
Paravertebral gutter in posterobasal 
Posterior and superior position 
Other position 
15 (75.0) 
4 (20.0) 
1 (5.0) 
14 (70.0) 
2 (10.0) 
4 (20.0) 
STATISTICAL ANALYSIS 
Comparison between two groups was made by x2 test. 
PcO.05 was considered as significant. 
Results 
Patients with massive pleural effusion due to lung cancer 
were prospectively entered into this study. Twenty patients 
were entered in this study and the patients’ characteristics 
are summarized in Table 1. None of the patients were 
receiving systemic chemotherapy until the removal of the 
chest tube. 
We evaluated the position of the tip of the chest tube 
after placement. In 15 patients (75.0%) it was positioned at 
the paravertebral gutter in posterobasal. The tip of the 
chest tube was found to be located at the posterior and 
superior position in four patients (20.0%) and at another 
position in the pleural space in one patient (5.0%) (Table 2). 
Just before removal, we evaluated again the position of the 
chest tube. In one out of the 15 patients whose tube had 
initially been placed at the paravertebral gutter in postero- 
basal and in two patients whose tube had been placed at the 
posterior and superior position the tip of the chest tube 
was noted to have been displaced during the drainage as 
documented on plain chest X-ray on removal of the tube 
(Table 2). All the patients were in a recumbent or seated 
position during drainage. 
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TABLE 3. Position of the tip of the chest tube and the drainage efficacy 
Drainage efficacy 
More than 90% 75590% Less than 75% 
Paravertebral gutter in posterobasal 13 2 0 
Posterior and superior position 1 2 1 
Other position 0 0 1 
We assessed the relationship between the position of the 
tip of the chest tube and drainage efficacy. A drainage 
efficacy of more than 90% was achieved in 13 patients 
(86.7%) of the 15 patients whose tip was placed at the 
paravertebral gutter in posterobasal (paravertebral- 
positioned group). On the other hand, however, only one 
patient (25.0%) whose catheter tip was at the posterior and 
superior position (posterosuperior-positioned group) had 
a drainage efficacy of more than 90%. A higher drainage 
efficacy of pleural effusion was observed in the para- 
vertebral group than in the posterosuperior-positioned 
group (P=O.O24) or other-positioned group (P<O.OOOl) 
(Table 3). The average times of drainage before and after 
applying OK-432 were 5 days (range of 1-8 days) and 
4 days (range l-8 days), respectively. 
We did not find any disadvantages of this curved catheter 
such as tube obstruction by clots or excessive curving when 
the lung has been re-expanded. None of the 20 patients 
reported significant pain (grade 1 or more of the WHO 
toxicity criteria) during catheter placement, although there 
were two patients who complained of mild discomfort at 
the chest tube site during drainage (one patient whose tube 
was positioned in the paravertebral gutter and the other 
patient whose tube was positioned at the posterior and 
superior position). 
After the effusions had been drained, all patients under- 
went chemical pleurodesis. The procedure was successful 
in all 20 patients according to the criteria of Paladine et al. 
(16). However, in six patients whose tube was mal- 
positioned before the removal, complete radiographic 
resolution of pleural effusion was not achieved, although no 
significant reaccumulation of effusion occurred for more 
than 4 weeks as defined by the criteria (16). 
Discussion 
Many approaches have been used to alleviate clinical 
symptoms from malignant pleural effusions. Because 
patients with malignant pleural effusion have a short life 
expectancy, less invasive methods are more desirable. How- 
ever repeated thoracenteses and tube thoracostomy alone 
are not sufficient, since pleural effusion reaccumulates 
quickly in these patients (2,3,17,18). Tube thoracostomy 
with a chest tube and instillation of a sclerosing agent into 
the pleural space is currently the most common method 
of treatment (4,19,20). Agents that have been used for 
chemical pleurodesis include talc, tetracycline, doxycycline, 
bleomycin and CryneDacteviunz parvum (21). OK-432 is a 
streptococcal preparation and has been shown to be an 
effective immunotherapy for patients with malignant 
pleural effusion (12). As a chemical sclerosing agent, 
OK-432 was successful in 88-100% of patients when 
instilled through a conventional chest tube (lo,1 1). The 
success rate depends not only on sclerosing agent used but 
also on complete drainage of the effusion. Therefore, 
positioning of the tip of the catheter in the space where the 
accumulation of effusion is expected is essential. It has been 
reported that 15-26% of catheters had to be repositioned or 
replaced because of malposition (22, 23). In our study with 
the new chest tube, malposition was observed only in one of 
20 patients (5%). There was no significant complication. 
There have been conflicting views regarding the ideal 
positioning of the tip of a chest tube where evacuation holes 
have been opened. In the supine position, pleural effusion 
collects posteriorly in the paravertebral gutters (13). 
McFadden et al. reported that the posterior and superior 
position is preferred for effusions resulting from both 
malignant and inflammatory conditions (14). However, 
there has been no comparative study to prove where the 
ideal position of the tip of the chest tube is. In patients 
without pleural adhesions and/or loculated effusion, we 
would like to emphasize that it remains controversial as to 
where to place the tip of a chest tube. 
Traditionally, tube thoracostomy and pleurodesis have 
been performed by using large-bore chest tubes; however, 
recent reports have suggested that small-bore catheters can 
be used with equal success for drainage and sclerosis 
(24-26). In addition to the overall efficacy of small-bore 
catheters, the advantages of using sonographic guidance 
for placement rather than blind insertion of large-bore 
chest tubes include less traumatic complication and better 
tolerance by patients of small-bore catheters than of the 
larger catheters. Use of small-bore catheters with ultrasono- 
graphic guidance also has an advantage of accurate place- 
ment especially for the treatment of pleural effusion with 
fibrin septation and/or multiloculation (26). In previous 
studies (24-26) no complication caused by tube obstruction 
by clots or excessive curving due to small calibre of the chest 
tube was reported. We did not find any disadvantage of this 
curved chest tube in the present study. 
Recently, video-assisted thoracic management has been 
reported as another new approach to malignant pleural 
effusion. It is a procedure that affords excellent visualiz- 
ation of the entire pleural space (27729). With the tech- 
nique, all the pleural effusion can be completely drained 
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and chemical pleurodesis can be performed. Visual place- 
ment of the chest tube may also be easily accomplished 
using the videoscope. It is usually performed in an operat- 
ing room, and this approach is more time consuming and 
expensive than chest tube placement at the bedside. More- 
over, as the majority of the candidates may have serious 
and advanced disease, and the procedure is usually per- 
formed under local (30) or general (31) anaesthesia with 
selective one-lung ventilation (32), physicians and surgeons 
should keep in mind the risk of serious complications. 
The procedure with this new curved chest tube is as 
simple as with the conventional one. It appears safe as we 
did not encounter any significant complication in the 20 
patients. This study suggested that the curved chest tube 
is safe and useful obtaining the complete evacuation of 
pleural effusion; therefore, it is now necessary to perform 
controlled studies comparing this curved chest tube with the 
large-bore one or small-bore catheter with or without 
ultrasonographic guidance. 
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